This company has been acquired
NTUS Stock Overview
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Natus Medical Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$32.96 |
| 52 Week High | US$33.93 |
| 52 Week Low | US$20.90 |
| Beta | 0.23 |
| 1 Month Change | 2.08% |
| 3 Month Change | -1.38% |
| 1 Year Change | 34.37% |
| 3 Year Change | 23.22% |
| 5 Year Change | -8.06% |
| Change since IPO | 128.10% |
Recent News & Updates
Recent updates
Novanta to replace Six Flags Entertainment in S&P MidCap 400, Six Flags to replace Natus Medical in S&P SmallCap 600
Jul 22Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital
Mar 04
Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital
Nov 08We Like Natus Medical's (NASDAQ:NTUS) Earnings For More Than Just Statutory Profit
Aug 13Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?
Aug 02We Think Shareholders Are Less Likely To Approve A Pay Rise For Natus Medical Incorporated's (NASDAQ:NTUS) CEO For Now
Jun 10Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)
May 05Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?
Feb 15
Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)
Jan 11Reflecting on Natus Medical's (NASDAQ:NTUS) Share Price Returns Over The Last Five Years
Dec 07Shareholder Returns
| NTUS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0.8% | -4.1% | -3.5% |
| 1Y | 34.4% | 2.2% | 20.2% |
Return vs Industry: NTUS exceeded the US Medical Equipment industry which returned -23.9% over the past year.
Return vs Market: NTUS exceeded the US Market which returned -15.4% over the past year.
Price Volatility
| NTUS volatility | |
|---|---|
| NTUS Average Weekly Movement | 2.2% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NTUS has not had significant price volatility in the past 3 months.
Volatility Over Time: NTUS's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 1,400 | Tom Sullivan | www.natus.com |
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories.
Natus Medical Incorporated Fundamentals Summary
| NTUS fundamental statistics | |
|---|---|
| Market cap | US$1.13b |
| Earnings (TTM) | US$12.68m |
| Revenue (TTM) | US$478.30m |
89.0x
P/E Ratio2.4x
P/S RatioIs NTUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NTUS income statement (TTM) | |
|---|---|
| Revenue | US$478.30m |
| Cost of Revenue | US$199.61m |
| Gross Profit | US$278.70m |
| Other Expenses | US$266.01m |
| Earnings | US$12.68m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.37 |
| Gross Margin | 58.27% |
| Net Profit Margin | 2.65% |
| Debt/Equity Ratio | 0% |
How did NTUS perform over the long term?
See historical performance and comparison